Association Between Integrated Specialty Pharmacy Care Model and Pharmaceutical Access and Costs
Clicks: 1
ID: 322467
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #73 of 89 articles by views in Health Affairs Scholar
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Introduction Healthcare consolidation in the United States has yielded mixed outcomes for patients, however, little is known about the impact of integration between insurers and specialty pharmacies. Through improved data and clinical integration, integrated specialty pharmacy care models may improve health care access and reduce costs for beneficiaries. However, this type of vertical integration may allow increased market power, which could lead to higher costs for beneficiaries. Methods Using [redacted] prescription claims, our cross-sectional study used adjusted regression analyses evaluating the association between the use of an integrated specialty pharmacy care model with pharmaceutical access and costs for beneficiaries managing complex specialty conditions in 2024. Results After adjusting for demographic and clinical characteristics, the integrated specialty pharmacy care model was associated with fewer days from prescription to fill (-5.7 days, 95% CI: : -6.7, -4.7), reduced yearly beneficiary pharmacy costs (-$106, 95% CI: -$163, -$49) and yearly beneficiary costs for the specialty drug (-$77, 95% CI: -$129, -$27) compared to non-integrated specialty pharmacies. We found additional benefits for beneficiaries who also used integrated primary care services. Conclusion Integrated specialty pharmacy care models may deliver faster and less costly pharmaceutical care for beneficiaries.
| Reference Key |
openalex_W7170196720
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Alexandra Glynn, Geronimo Bejarano, Insiya B. Poonawalla |
| Journal | Health Affairs Scholar |
| Year | 2026 |
| DOI |
10.1093/haschl/qxag192
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.